Efficacy of rituximab for the treatment of refractory inflammatory myopathies associated with anti-histidyl-tRNA synthetase antibodies (the FORCE Jo1 Study) - Allenbach, Y; Rigolet, A; Guiguet, M
. ACR Kongress 2012, Abstract 220.